AI
Thursday, September 13, 2012 7:39:04 AM
GENT. Gentium Reports First Half 2012 Financial Results
http://finance.yahoo.com/news/gentium-reports-first-half-2012-110000712.html
Defibrotide usage increased 38% to EUR 11.35 million (USD 14.29 million) for the six-month period ended June 30, 2012 from EUR 8.23 million in the prior-year period
Product sales of EUR 13.68 million (USD 17.22 million) for the six-month period ended June 30, 2012, recording an increase of EUR 2.88 million or 27%
Non-GAAP adjusted EBITDA of EUR 1.86 million (USD 2.34 million) for the first half of 2012
http://finance.yahoo.com/news/gentium-reports-first-half-2012-110000712.html
Defibrotide usage increased 38% to EUR 11.35 million (USD 14.29 million) for the six-month period ended June 30, 2012 from EUR 8.23 million in the prior-year period
Product sales of EUR 13.68 million (USD 17.22 million) for the six-month period ended June 30, 2012, recording an increase of EUR 2.88 million or 27%
Non-GAAP adjusted EBITDA of EUR 1.86 million (USD 2.34 million) for the first half of 2012
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
